Literature DB >> 19519642

Tyrosine hydroxylase-immunoreactive neurons are decreased in number in the cerebral cortex of Parkinson's disease.

T Fukuda1, J Takahashi, J Tanaka.   

Abstract

Tyrosine hydroxylase (TH)-immunoreactive (IR) neurons and their relationship with Lewy bodies were investigated in Parkinson's disease. Using anti-TH and/or anti-ubiquitin antibodies, we evaluated the cerebral cortices included superior frontal gyrus, precentral gyrus, postcentral gyrus, inferior temporal gyrus, cuneus, cingulate gyrus, short and long gyri of insula, and parahippocampal gyrus from 18 autopsy cases of Parkinson's disease and 16 controls. The appearance of TH-IR neurons in cerebral cortices was suggestive of non-pyramidal interneurons. The mean number of TH-IR neurons and the density of TH-IR fibers in Parkinson's disease were decreased in comparison with the controls. The cognitive impairment in Parkinson's disease has been accounted for by the lesions of the basal nucleus of Meynert, the locus ceruleus, and the cortical Lewy bodies in the cerebral cortex. In addition to these lesions, the global loss of non-pyramidal TH-IR cortical neurons and TH-IR fibers would induce the dysfunction of higher-order control of the neocortex and the limbic system in Parkinson's disease. Double-immunostaining with anti-TH and anti-ubiquitin antibodies did not show the TH-IR neuron with cortical Lewy body in the cerebral cortices of Parkinson's disease. In the cerebral cortices of Parkinson's disease, TH-IR non-pyramidal neurons in which cortical Lewy body is not formed decreased in number.

Entities:  

Year:  1999        PMID: 19519642     DOI: 10.1046/j.1440-1789.1999.00196.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  11 in total

1.  Species-specific distributions of tyrosine hydroxylase-immunoreactive neurons in the prefrontal cortex of anthropoid primates.

Authors:  M A Raghanti; M A Spocter; C D Stimpson; J M Erwin; C J Bonar; J M Allman; P R Hof; C C Sherwood
Journal:  Neuroscience       Date:  2008-11-07       Impact factor: 3.590

2.  Neurochemical characterization of tyrosine hydroxylase-immunoreactive interneurons in the developing rat cerebral cortex.

Authors:  Stephen E Asmus; Emily K Anderson; Mark W Ball; Brock A Barnes; Angela M Bohnen; Alexander M Brown; Lucinda J Hartley; Matthew C Lally; Tammy M Lundblad; Joshua B Martin; Benjamin D Moss; Kevin D Phelps; Laura R Phillips; Cara G Quilligan; Ryan B Steed; Shariya L Terrell; Ashley E Warner
Journal:  Brain Res       Date:  2008-05-28       Impact factor: 3.252

3.  Cortical gray and subcortical white matter associations in Parkinson's disease.

Authors:  Nicholas W Sterling; Guangwei Du; Mechelle M Lewis; Steven Swavely; Lan Kong; Martin Styner; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2016-09-28       Impact factor: 4.673

4.  Increasing proportions of tyrosine hydroxylase-immunoreactive interneurons colocalize with choline acetyltransferase or vasoactive intestinal peptide in the developing rat cerebral cortex.

Authors:  Stephen E Asmus; Benjamin T Cocanougher; Donald L Allen; John B Boone; Elizabeth A Brooks; Sarah M Hawkins; Laura A Hench; Talha Ijaz; Meredith N Mayfield
Journal:  Brain Res       Date:  2011-02-03       Impact factor: 3.252

5.  Tyrosine hydroxylase-producing neurons in the human cerebral cortex do not colocalize with calcium-binding proteins or the serotonin 3A receptor.

Authors:  Stephen E Asmus; Mary Ann Raghanti; Eric R Beyerle; Julia C Fleming-Beattie; Sarah M Hawkins; Courtney M McKernan; Nicholas A Rauh
Journal:  J Chem Neuroanat       Date:  2016-07-20       Impact factor: 3.052

6.  Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson's disease.

Authors:  Amélie C Lanoue; Gene J Blatt; Jean-Jacques Soghomonian
Journal:  Brain Res       Date:  2013-07-23       Impact factor: 3.252

7.  Stage-dependent loss of cortical gyrification as Parkinson disease "unfolds".

Authors:  Nicholas W Sterling; Ming Wang; Lijun Zhang; Eun-Young Lee; Guangwei Du; Mechelle M Lewis; Martin Styner; Xuemei Huang
Journal:  Neurology       Date:  2016-02-17       Impact factor: 9.910

8.  Molecular and cellular reorganization of neural circuits in the human lineage.

Authors:  André M M Sousa; Ying Zhu; Mary Ann Raghanti; Robert R Kitchen; Marco Onorati; Andrew T N Tebbenkamp; Bernardo Stutz; Kyle A Meyer; Mingfeng Li; Yuka Imamura Kawasawa; Fuchen Liu; Raquel Garcia Perez; Marta Mele; Tiago Carvalho; Mario Skarica; Forrest O Gulden; Mihovil Pletikos; Akemi Shibata; Alexa R Stephenson; Melissa K Edler; John J Ely; John D Elsworth; Tamas L Horvath; Patrick R Hof; Thomas M Hyde; Joel E Kleinman; Daniel R Weinberger; Mark Reimers; Richard P Lifton; Shrikant M Mane; James P Noonan; Matthew W State; Ed S Lein; James A Knowles; Tomas Marques-Bonet; Chet C Sherwood; Mark B Gerstein; Nenad Sestan
Journal:  Science       Date:  2017-11-24       Impact factor: 47.728

9.  Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice.

Authors:  Xiaojin Shi; Yu-Hua Chen; Hao Liu; Hong-Dang Qu
Journal:  Mol Med Rep       Date:  2016-07-28       Impact factor: 2.952

Review 10.  Structural Imaging and Parkinson's Disease: Moving Toward Quantitative Markers of Disease Progression.

Authors:  N W Sterling; M M Lewis; G Du; X Huang
Journal:  J Parkinsons Dis       Date:  2016-05-27       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.